Shortly after Congress amended the Toxic Substances Control Act in 2016, the EPA began the rulemaking process on 10 chemicals currently in use in the United States using a broad and overreaching definition of "Unreasonable risk." Now, the EPA is expected to release a final rule on methylene chloride under TSCA. New Deals At The Gateway Pundit Discounts Page At MyPillow - Up to 71% Off With Promo Code TGP Methylene chloride has several applications, including in the process of manufacturing hundreds of medicines and vaccines like those that treat Hepatitis B and HIV infections, mental illnesses and epilepsy, heart failure and high blood pressure, and high cholesterol.
Methylene chloride is used to make hollow fiber cartridges which are used in the manufacture of monoclonal antibodies and vaccines, including the COVID-19, HPV, Hepatitis B, and flu vaccines, as well as therapies for arthritis, migraines, osteoporosis, and autoimmune diseases.
In a letter to the EPA, the company that produces these cartridges wrote their product is used in at least 190 human therapeutics and vaccines.
Their supply is so essential that the U.S. Department of Health and Human Services and the Defense Department awarded the company funding to expand its manufacturing capacity here in the U.S. While HHS and DoD give taxpayer money to this company to operate in the United States, the EPA is simultaneously regulating out of domestic existence the necessary ingredients for their products.
Ultimately, the final EPA rule could "Impact millions of patients worldwide." Another company warned the EPA ban "Would disrupt the critical infrastructure of biotechnology, including medical uses such as vaccine manufacturing and industrial biotechnology." While the EPA would argue that pharmaceutical usage is exempt from the rule, the upstream supply chain of products necessary to manufacture these medicines is not.
The biggest winner with this new EPA rule will be China, which has grown to be the largest chemical producer in the world and the top exporter of methylene chloride.
Despite the Biden administration's stated goal to reduce "Reliance on high-risk foreign suppliers" for medicines, the EPA is actively stifling the domestic production of ingredients needed to manufacture life-saving drugs that Americans rely on.
https://www.thegatewaypundit.com/2024/05/historic-drug-shortage-exacerbated-epa-overreach/
No comments:
Post a Comment